Nuzenio

Actio Bio Acquisition

Actio Bio Acquisition news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 22:02:41 GMTJazz Pharma Expands Again in Epilepsy With $820M Actio Bio Acquisition - MedCity News
Mon, 10 Aug 2026 16:17:36 GMTJazz Pharmaceuticals expands rare epilepsy pipeline with Actio Biosciences deal - European Pharmaceutical Review
Mon, 10 Aug 2026 16:06:35 GMTJazz to buy rare epilepsy drugmaker in potentially $1.3B deal - BioPharma Dive
Mon, 10 Aug 2026 15:16:17 GMTJazz expands epilepsy portfolio with buy of Actio Biosciences - The Pharma Letter
Mon, 10 Aug 2026 15:11:12 GMTJazz bets on epilepsy treatment with up to $1.32 billion deal for Actio - Reuters
Mon, 10 Aug 2026 14:55:28 GMTJazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline - BioSpace

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Actio Bio Acquisition.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.